Seer, Inc.
Company Information
Industry
Laboratory Analytical Instruments
SIC Code
3826
Entity Type
operating
SEC Category
Non-accelerated filerSmaller reporting company
State of Incorporation
DE
Business Address
3800 BRIDGE PARKWAY, SUITE 102, REDWOOD CITY, CA, 94065
Mailing Address
3800 BRIDGE PARKWAY, SUITE 102, REDWOOD CITY, CA, 94065
Phone
650-453-0000
Fiscal Year End
1231
EIN
821153150
Recent SEC Filings
| Form Type | Date Filed | Document |
|---|---|---|
| 8-K Current report of material events | March 30, 2026 | View on SEC |
| 8-K Current report of material events | March 16, 2026 | View on SEC |
| SCHEDULE 13D/A Beneficial ownership amendment | March 2, 2026 | View on SEC |
| 10-K Annual financial report | March 2, 2026 | View on SEC |
| 8-K Current report of material events | February 26, 2026 | View on SEC |
| 8-K Current report of material events | February 26, 2026 | View on SEC |
| SCHEDULE 13D Beneficial ownership report (>5%) | February 20, 2026 | View on SEC |
| 4 Insider stock transaction report | February 19, 2026 | View on SEC |
| 4 Insider stock transaction report | February 19, 2026 | View on SEC |
| 4 Insider stock transaction report | February 5, 2026 | View on SEC |
Annual Reports
10-K
March 2, 2026
- Strong revenue growth of approximately 29% year-over-year in 2025, reaching $28.5 million, driven by product sales and services.
- Proprietary Proteograph™ Product Suite offers a unique competitive advantage in comprehensive, unbiased protein analysis, aiming to speed up discoveries.
Insider Trading
SELL
2 insiders
2 recent transactions
View Full Insider Trading Profile
Related Companies
Companies in the same industry (SIC: 3826)
Investor Resources
Learn more about SEC filings and how to research public companies.
What is the SEC?
A plain English guide to the Securities and Exchange Commission
Understanding SEC Filings & CIK
How to navigate SEC filings and Central Index Keys
10-K Annual Reports Explained
Everything you need to know about annual reports
S-1 & F-1 IPO Filings
Understanding IPO registration statements
SEC EDGAR Database Guide
How to use the SEC's free filing database
Important Disclaimer
This AI-generated analysis is for informational purposes only and does not constitute financial or investment advice. Always consult with qualified professionals and conduct your own research before making investment decisions.